I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 21% ± 3% | |
| natural killer cell | 8 studies | 21% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 27% ± 8% | |
| CD8-positive, alpha-beta T cell | 4 studies | 22% ± 4% | |
| mature NK T cell | 4 studies | 19% ± 2% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| exhausted T cell | 3 studies | 17% ± 1% | |
| regulatory T cell | 3 studies | 16% ± 0% | |
| classical monocyte | 3 studies | 18% ± 3% | |
| dendritic cell | 3 studies | 27% ± 5% | |
| non-classical monocyte | 3 studies | 28% ± 10% | |
| goblet cell | 3 studies | 17% ± 0% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 2% | |
| gamma-delta T cell | 3 studies | 20% ± 2% | |
| double negative thymocyte | 3 studies | 16% ± 1% |
